Xiaomin Xu

Title: Innovations of Xiaomin Xu in Non-Steroidal Anti-Inflammatory Medicaments

Introduction

Xiaomin Xu is an innovative inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal anti-inflammatory medicaments. His work focuses on enhancing the efficacy and safety of these medications, making them suitable for a broader range of patients.

Latest Patents

Xiaomin Xu holds a patent for "Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing the same." This invention involves the design and synthesis of ascorbyl ester derivatives of aryl (ethanoic) propanoic acid, which includes well-known medications such as ibuprofen, ketoprofen, and naproxen. The patented formulation demonstrates remarkable antipyretic and analgesic effects, making it suitable for various age groups, including infants and the elderly. The invention also improves water solubility, facilitates intravenous administration, and enhances bioavailability while reducing gastrointestinal stimulation.

Career Highlights

Xiaomin Xu has worked with Wuxi Hongrui Bio-Pharma-Tech Co., Ltd., where he has contributed to the advancement of pharmaceutical technologies. His innovative approach has led to the development of novel medicaments that address various medical conditions, including arthritis, dysmenorrhea, and certain cancers.

Collaborations

Xiaomin Xu has collaborated with notable colleagues, including Ze Wang and Ajuan Dai, who have contributed to his research and development efforts in the pharmaceutical field.

Conclusion

Xiaomin Xu's contributions to the field of non-steroidal anti-inflammatory medicaments highlight his innovative spirit and dedication to improving patient care. His patented inventions pave the way for safer and more effective treatments for a variety of medical conditions.